# Effectiveness of Seasonal Malaria Chemoprevention in Nampula Province, Mozambique: Type Two Hybrid Implementation Study

> **NCT05186363** · PHASE4 · UNKNOWN · sponsor: **Malaria Consortium** · enrollment: 3156 (actual)

## Conditions studied

- Malaria

## Interventions

- **DRUG:** Chemopreventive Agent - SPAQ
- **DRUG:** Control Test - no drugs given

## Key facts

- **NCT ID:** NCT05186363
- **Lead sponsor:** Malaria Consortium
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-01-08
- **Primary completion:** 2022-06-21
- **Final completion:** 2023-12-01
- **Target enrollment:** 3156 (ACTUAL)
- **Last updated:** 2023-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05186363

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05186363, "Effectiveness of Seasonal Malaria Chemoprevention in Nampula Province, Mozambique: Type Two Hybrid Implementation Study". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT05186363. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*